Medical slings

• US 7,070,558 B2
• Filed: 06/12/2003
• Issued: 07/04/2006
• Est. Priority Date: 07/27/2001
• Status: Expired due to Fees

• Current Assignee: Boston Scientific Scimed, Inc. (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Scimed, Inc. (Boston Scientific Corporation)
• Inventors: Madenjian, Art, Rao, Doreen, Gellman, Barry
• Primary Examiner(s): Gilbert, Samuel G.
• Application Number:
  US10/460,112
• Publication Number:
  US 20040039246A1
• Time in Patent Office: 1,118 Days
• Field of Search: 600 29- 32, 600/36, 600/37, 606151-158, 623/1.1, 623 138- 154, 623/11.11, 623/13.14, 128/839
• US Class Current: 600/37
• CPC Class Codes: A61F 2/0036 implantable A61F2/0018 takes precedence
• CPC Class Codes: A61F 2/0045 Support slings
• CPC Class Codes: A61F 2/0063 Implantable repair or support meshes, e.g. hernia meshes
• CPC Class Codes: A61F 2/0095 Packages or dispensers for prostheses or other implants for intraocular lenses A61F2/1691; for dental surgery A61C19/02
• CPC Class Codes: A61F 2210/0004 bioabsorbable
• CPC Class Codes: A61F 2240/001 Designing or manufacturing processes
• CPC Class Codes: A61F 2250/0097 Visible markings, e.g. indicia
• CPC Class Codes: Y10T 29/49 Method of mechanical manufacture

Abstract

A sling in accordance with the invention includes a synthetic material and a non-synthetic material positioned adjacent thereto. The non-synthetic material may be wrapped around or may be attached to the synthetic material. Additionally, the non-synthetic material may include slits. Methods for making such slings are also described.

Claims

1. A sling for treating urinary incontinence, comprising:

a first implantable sheet sized and shaped to fit under and for supporting a urethra of a patient, the first sheet comprising a synthetic material having a width of between about 1 cm and about 3 cm and a length of between about 1 cm and about 30 cm, having first and second ends, and having upper and lower sides,

a first mammalian tissue material attached to the upper side of the first sheet between the first and second ends spanning substantially the entire width of the first sheet and at least a portion of the length of the first sheet, for being interdisposed between the upper side of the first sheet and the urethra, the attachment being by at least one of glue, suture, stable, rivet, eyelet rivet, and clip, and

a second mammalian tissue material attached to the lower side of the first implantable sheet opposite the first mammalian tissue material, the attachment being by at least one of glue, suture, staple, rivet, and clip.

2. The sling of claim 1 wherein the first mammalian tissue material is disposed adjacent to a urethra when placed within a body of a patient.

3. The sling of claim 1 wherein the first mammalian tissue material can extend to each side of an endopelvic fascia when placed within a body of a patient.

4. The sling of claim 1 wherein the first mammalian tissue material comprises an acellular matrix processed from human or bovine dermis.

5. The sling of claim 1 wherein the first mammalian tissue is capable of remodeling into a healthy layer of tissue.

6. The sling of claim 1 wherein at least a portion of the first implantable sheet is tanged.

7. The sling of claim 1 wherein the first implantable sheet comprises fibers selected from the group consisting of colored, radiopaque, and combinations thereof.

8. The sling of claim 1 wherein the first implantable sheet is of a type selected from the group consisting of woven, knitted, felted, and combinations thereof.

9. The sling of claim 1 wherein the sheet comprises a coating.

10. The sling of claim 9 wherein the coating comprises a pharmaceutical for delivery to a patient when the sling is implanted in a body of the patient.

11. The sling of claim 1 wherein the synthetic material is at least one material selected from the group consisting of nylon, polyethylene, polyester, polypropylene, and fluoropolymers.

12. The sling of claim 1 wherein the first mammalian tissue material is about 4 cm to about 10 cm in length along the first axis of the sheet.

13. The sling of claim 1 wherein the first mammalian tissue material is selected from the group consisting of bovine, porcine, ovine, equine, human cadaveric, and tissue-engineered tissues.

14. The sling of claim 1 wherein the first mammalian tissue material includes one or more slits.

15. The sling of claim 14 wherein at least one of the one or more slits opens upon exposure to a tensioning force applied during a medical application.

16. The sling of claim 14 wherein each of the slits comprises an aperture.

17. The sling of claim 16 wherein at least some of the apertures remain open after exposure to a tensioning force applied during a medical application.

18. A method of making a sling for treating urinary incontinence, comprising:

providing a first implantable sheet suitable for treating urinary incontinence, and sized and shaped to fit under and for supporting a urethra of a patient, the first sheet comprising a synthetic material having a width of between about 1 cm and about 3 cm and a length of between about 1 and about 30 cm, having first and second ends, and having upper and lower sides,

attaching first mammalian tissue material to the upper side of the first sheet between the first and second ends, the first mammalian tissue material spanning substantially the entire width of the first sheet and at least a portion of the length of the first implantable sheet, for being interdisposed between the upper side of the first sheet and the urethra, the attachment being by at least one of glue, suture, staple, rivet, eyelet rivet, and clip, and

attaching a second mammalian tissue material attached to the lower side of the first implantable sheet opposite the first mammalian tissue material, the attachment being by at least one of glue, suture, staple, rivet, eyelet rivet, and clip.